Connect with us


30,000 Cannabis Studies Done and Dusted: but More Research is Still Needed?

Updated on
Anyone conversant with the medical cannabis scene is probably familiar with the all too common “in conclusion” disclaimer; but more research is needed to confirm these preliminary findings. It’s a way to neatly counter all substantial evidence supporting marijuana’s therapeutic potential. So one would easily assume that researchers are only beginning to scratch the surface with medical cannabis. A recent study has revealed quite the contrary.
Nearly 30,000 cannabis related studies were carried out between 1829 and 2021. These studies have been published in close to 6,000 scientific journals including the British Journal of Pharmacology (356), the Journal of Drug and Alcohol Dependence (706), and Addictive Behaviors (419).
The researchers noted a steep increase in the number of cannabis related studies from the 1960’s. While earlier as well as the bulk of the studies focused on the harms of cannabis, later studies have concentrated on the therapeutic potential. In addition, later studies have had a broader scope  with researchers relying on several databases such as Scopus.
The researchers noted that the spike in cannabis research can be attributed to increased funding opportunities. For example, from 2000 to 2018, cannabis researchers were funded to the tune of $1.5 billion.  It is presumed that most of these funds were channeled towards investigating the risks and benefits of medical cannabis. However, the researchers noted that earlier studies that were mostly funded by NIDA were framed to find  “whats wrong with cannabis” and not “what’s right with cannabis.” With such a background, it’s no surprise that cannabis researchers still walk on eggshells when declaring results that seem to support the therapeutic potential of the plant. Hence the entrenchment of the disclaimer, “further research is needed to confirm the preliminary findings.” 30,000 studies and counting . . .

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.

Posts/Pages Sidebar Form

Advertiser Disclosure: is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed.

Educational & Medical Disclaimer: This information is for educational purposes only. We are not medical professionals, and no information on this website should be construed as medical advice. For more information please view our Educational & Medical Disclaimer.

Minimum Age: To use this website you must be the minimum age as allowed in your jurisdiction. USA visitors must be 21, visitors from Canada must be 18 or 19 years of age depending on the province. It is illegal for a person younger than this to use this website.